Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ASTH Astrana Health Inc.
- Stocks
- Healthcare
- NASDAQ: ASTH
Price (delayed)
$25.36
Market cap
$1.42B
P/E Ratio
34.27
Dividend/share
N/A
EPS
$0.74
Enterprise value
$1.61B
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based
Highlights
The revenue has soared by 55% year-on-year and by 11% since the previous quarter
Astrana Health's equity has increased by 14% YoY and by 4.6% from the previous quarter
The price to earnings (P/E) is 9% higher than the 5-year quarterly average of 33.2 but 3% lower than the last 4 quarters average of 37.2
Astrana Health's quick ratio has increased by 8% YoY but it has decreased by 2.5% from the previous quarter
Astrana Health's net income has decreased by 44% YoY and by 19% QoQ
The EPS has declined by 44% year-on-year and by 19% since the previous quarter
Key stats
What are the main financial stats of ASTH
Market
Valuations
Earnings
Shares outstanding
56.06M
Market cap
$1.42B
Enterprise value
$1.61B
Price to earnings (P/E)
34.27
Price to book (P/B)
1.91
Price to sales (P/S)
0.63
EV/EBIT
17
EV/EBITDA
12.61
EV/Sales
0.72
Revenue
$2.25B
Gross profit
$268.76M
Operating income
$79.79M
Net income
$35.01M
EBIT
$94.95M
EBITDA
$128.04M
Free cash flow
$52.12M
Per share
Balance sheet
Liquidity
EPS
$0.74
EPS diluted
$0.73
Free cash flow per share
$0.93
Book value per share
$13.25
Revenue per share
$40.01
TBVPS
$14.27
Total assets
$1.33B
Total liabilities
$813.55M
Debt
$451.35M
Equity
$745.37M
Working capital
$252M
Debt to equity
0.61
Current ratio
1.7
Quick ratio
1.59
Net debt/EBITDA
1.51
Margins
Efficiency
Dividend
EBITDA margin
5.7%
Gross margin
11.9%
Net margin
1.6%
Operating margin
3.5%
Return on assets
2.7%
Return on equity
4.9%
Return on invested capital
15.7%
Return on capital employed
9.8%
Return on sales
4.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ASTH stock price
How has the Astrana Health stock price performed over time
Intraday
-5.02%
1 week
4.53%
1 month
4.41%
1 year
-35.86%
YTD
-19.57%
QTD
-18.22%
Financial performance
How have Astrana Health's revenue and profit performed over time
Revenue
$2.25B
Gross profit
$268.76M
Operating income
$79.79M
Net income
$35.01M
Gross margin
11.9%
Net margin
1.6%
The net margin has dropped by 63% year-on-year and by 24% since the previous quarter
The revenue has soared by 55% year-on-year and by 11% since the previous quarter
The company's operating margin fell by 45% YoY and by 20% QoQ
Astrana Health's net income has decreased by 44% YoY and by 19% QoQ
Price vs fundamentals
How does ASTH's price correlate with its fundamentals
Growth
What is Astrana Health's growth rate over time
Valuation
What is Astrana Health stock price valuation
P/E
34.27
P/B
1.91
P/S
0.63
EV/EBIT
17
EV/EBITDA
12.61
EV/Sales
0.72
The EPS has declined by 44% year-on-year and by 19% since the previous quarter
The price to earnings (P/E) is 9% higher than the 5-year quarterly average of 33.2 but 3% lower than the last 4 quarters average of 37.2
ASTH's price to book (P/B) is 56% lower than its 5-year quarterly average of 4.6 and 37% lower than its last 4 quarters average of 3.2
Astrana Health's equity has increased by 14% YoY and by 4.6% from the previous quarter
ASTH's P/S is 70% below its 5-year quarterly average of 2.2 and 44% below its last 4 quarters average of 1.2
The revenue has soared by 55% year-on-year and by 11% since the previous quarter
Efficiency
How efficient is Astrana Health business performance
Astrana Health's return on assets has shrunk by 54% YoY and by 21% QoQ
Astrana Health's return on equity has shrunk by 52% YoY and by 22% QoQ
The return on sales has declined by 47% year-on-year and by 21% since the previous quarter
The company's return on invested capital fell by 41% YoY and by 19% QoQ
Dividends
What is ASTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ASTH.
Financial health
How did Astrana Health financials performed over time
The total assets is 64% more than the total liabilities
The current ratio rose by 12% year-on-year but it has declined by 2.9% since the previous quarter
The total assets has grown by 9% YoY
The debt is 39% smaller than the equity
Astrana Health's equity has increased by 14% YoY and by 4.6% from the previous quarter
The company's debt to equity fell by 8% QoQ and by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.